Physician profile
Ryan Mcspadden
NPI 1427324417
$1,740.68
in general payments reported to CMS, 2019-2025
10 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.86 · 2020: $115 · 2022: $257 · 2023: $529 · 2024: $465 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $590.16 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Medtronic, INC. | $279.98 | 2023-2024 | Propel, Sinuva, Nim Vital |
| Aroa Biosurgery Incorporated | $158.10 | 2024 | |
| Stryker Corporation | $134.20 | 2022 | |
| Smith+Nephew, INC. | $126.45 | 2023 | Coblation |
| Glaxosmithkline, LLC. | $124.99 | 2023 | Nucala |
| Alk-Abello, INC | $115.00 | 2020 | |
| Cochlear Americas | $105.27 | 2022 | |
| Alkermes, INC. | $88.86 | 2019 | |
| Tactile Systems Technology INC | $17.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mcspadden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.